Total Artificial Heart - Medical Devices Pipeline Assessment, 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Research details developments in the <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Medical</strong><br />
<strong>Devices</strong> <strong>Pipeline</strong> <strong>Assessment</strong>, <strong>2016</strong><br />
The report analyzes and presents an overview of " <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Medical</strong><br />
<strong>Devices</strong> <strong>Pipeline</strong> <strong>Assessment</strong>, <strong>2016</strong> " worldwide.<br />
GlobalData's <strong>Medical</strong> <strong>Devices</strong> sector report, <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Medical</strong> <strong>Devices</strong> <strong>Pipeline</strong><br />
<strong>Assessment</strong>, <strong>2016</strong>" provides an overview of <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> currently in pipeline<br />
stage.<br />
The report provides comprehensive information on the pipeline products with comparative<br />
analysis of the products at various stages of development. The report reviews major players<br />
involved in the pipeline product development. It also provides information about clinical<br />
trials in progress, which includes trial phase, trial status, trial start and end dates, and, the<br />
number of trials for the key <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> pipeline products.<br />
This report is prepared using data sourced from inhouse databases, secondary and primary<br />
research by GlobalData's team of industry experts.<br />
Download Sample copy of this Report at<br />
http://www.marketresearchreports.biz/sample/sample/724128<br />
Scope<br />
Extensive coverage of the <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> under development<br />
The report reviews details of major pipeline products which includes, product description,<br />
licensing and collaboration details and other developmental activities<br />
The report reviews the major players involved in the development of <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong><br />
and list all their pipeline projects<br />
The coverage of pipeline products based on various stages of development ranging from<br />
Early Development to Approved / Issued stage<br />
The report provides key clinical trial data of ongoing trials specific to pipeline products<br />
Recent developments in the segment / industry<br />
Reasons to buy<br />
The report enables you to <br />
Formulate significant competitor information, analysis, and insights to improve R&D<br />
strategies<br />
Identify emerging players with potentially strong product portfolio and create effective
counterstrategies to gain competitive advantage<br />
Identify and understand important and diverse types of <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> under<br />
development<br />
Develop marketentry and market expansion strategies<br />
Plan mergers and acquisitions effectively by identifying major players with the most<br />
promising pipeline<br />
Indepth analysis of the products current stage of development, territory and estimated<br />
launch date<br />
Read our latest Press Release at http://www.marketresearchreports.biz/pressreleases<br />
Table of Contents<br />
1 Table of Contents 2<br />
1.1 List of Tables 4<br />
1.2 List of Figures 5<br />
2 Introduction 6<br />
2.1 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Overview 6<br />
3 Products under Development 7<br />
3.1 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products by Stage of Development 7<br />
3.2 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products by Territory 8<br />
3.3 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products by Regulatory Path 9<br />
3.4 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products by Estimated Approval Date 10<br />
3.5 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Ongoing Clinical Trials 11<br />
4 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products under Development by Companies 12<br />
4.1 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Companies <strong>Pipeline</strong> Products by Stage of Development 12<br />
4.2 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> <strong>Pipeline</strong> Products by Stage of Development 13<br />
5 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Companies and Product Overview 14<br />
5.1 Abiomed, Inc. Company Overview 14<br />
5.1.1 Abiomed, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 14<br />
5.2 BiVacor Pty Ltd Company Overview 16<br />
5.2.1 BiVacor Pty Ltd <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 16<br />
5.3 Carmat SAS Company Overview 17<br />
5.3.1 Carmat SAS <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 17<br />
5.4 Cleveland <strong>Heart</strong>, Inc. Company Overview 21<br />
5.4.1 Cleveland <strong>Heart</strong>, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 21<br />
5.5 FosterMiller, Inc. (Inactive) Company Overview 23<br />
5.5.1 FosterMiller, Inc. (Inactive) <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 23<br />
5.6 MicroMed Cardiovascular, Inc. Company Overview 24<br />
5.6.1 MicroMed Cardiovascular, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview<br />
24<br />
5.7 SynCardia Systems, Inc. Company Overview 25<br />
5.7.1 SynCardia Systems, Inc. <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 25<br />
5.8 The University of Tokyo Company Overview 34<br />
5.8.1 The University of Tokyo <strong>Pipeline</strong> Products & Ongoing Clinical Trials Overview 34<br />
6 <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Recent Developments 35<br />
6.1 Apr 13, <strong>2016</strong>: Worlds Leading <strong>Artificial</strong> <strong>Heart</strong> Center, La Piti Hospital, Paris, Celebrates<br />
30 Years and 249 Implants of the SynCardia <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> 35<br />
6.2 Feb 29, <strong>2016</strong>: Early Findings of the 50cc SynCardia <strong>Heart</strong> Indicate That It Fits<br />
Underserved Patients Women & Adolescents 36
6.3 Feb 26, <strong>2016</strong>: Carmat Raises USD55 Million in Private Placement of Shares 37<br />
6.4 Jan 26, <strong>2016</strong>: Altaris Capital Partners Acquires Minority Interest in Minnetronix for<br />
USD20 Million 37<br />
6.5 Jan 21, <strong>2016</strong>: Information regarding the Feasibility study of the CARMAT bioprosthetic<br />
artificial heart 37<br />
6.6 Nov 12, 2015: Arrhythmia Research Technology Reports 2015 Third Quarter Results 38<br />
6.7 Sep 16, 2015: SynCardia Systems Withdraws IPO for up to USD30 Million 39<br />
6.8 Aug 31, 2015: Interim Results of the Feasibility Study Presented at the ESC Congress in<br />
London 40<br />
6.9 Aug 18, 2015: The Start of SynCardia <strong>Total</strong> <strong>Artificial</strong> <strong>Heart</strong> Destination Clinical Study<br />
Wins Edison Awards Top Honor 40<br />
6.10 Jun 15, 2015: SynCardia Systems TAHt Companion 2 Driver System Letter to<br />
Health Care Providers 41<br />
6.11 Jun 03, 2015: Carmat To Implant <strong>Artificial</strong> <strong>Heart</strong> In Fourth Patient In Next Three<br />
Months 42<br />
7 Appendix 43<br />
7.1 Methodology 43<br />
7.2 About GlobalData 45<br />
7.3 Contact Us 46<br />
7.4 Disclaimer 46<br />
About us<br />
MarketResearchReports.biz is the most comprehensive collection of market research<br />
reports. MarketResearchReports.Biz services are specially designed to save time and money<br />
for our clients. We are a one stop solution for all your research needs, our main offerings<br />
are syndicated research reports, custom research, subscription access and consulting<br />
services. We serve all sizes and types of companies spanning across various industries.<br />
Contact<br />
Mr. Nachiket<br />
State Tower<br />
90 Sate Street, Suite 700<br />
Albany, NY 12207<br />
Tel: +15186212074<br />
Website: http://www.marketresearchreports.biz/<br />
E: sales@marketresearchreports.biz
Change language